Timothy J. Barberich, Director at TScan Therapeutics, Inc. (TCRX), bought 57,977 shares at $4.89 ($284K) on 2023-12-18, disclosed to the SEC on 2023-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.89 | 28,830 | $141K | 49.7% |
| 2 | $4.89 | 28,830 | $141K | 49.7% |
| 3 | $4.97 | 317 | $2K | 0.6% |
| Total | $4.89 avg | 57,977 | $284K | 100% |
| Filing → |
| VSTM | BUY | 2019-03-19 | $106K | — | Filing → |
| VSTM | BUY | 2018-10-02 | $37K | — | Filing → |
| VSTM | BUY | 2017-12-07 | $478K | — | Filing → |